News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lazar David E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4/A
| Lazar David E. (CEO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Sold 3,388,902 shares
@ $1.23, valued at
$4.2M
Sold 359,066 shares
@ $1.23, valued at
$441.7k
|
|
| 01/26/2023 |
4
| Lazar David E. (CEO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 37,500 shares
@ $0.9659, valued at
$36.2k
Bought 20,000 shares
@ $1.0033, valued at
$20.1k
|
|
| 12/07/2022 |
SC 13D/A
| Lazar David E. reports a 9.7% stake in Insignia Systems, Inc. |
| 11/25/2022 |
SC 13D/A
| Lazar David E. reports a 7.5% stake in Insignia Systems, Inc. |
| 07/11/2022 |
SC 13D/A
| Lazar David E. reports a 3.4% stake in Equus Total Return, Inc. |
| 07/08/2022 |
4
| Lazar David E. (10% Owner) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 1,165,975 shares
@ $0.7735, valued at
$901.9k
Bought 744,294 shares
@ $0.9929, valued at
$739k
Bought 315,921 shares
@ $0.8926, valued at
$282k
|
|
| 07/08/2022 |
3
| Lazar David E. (10% Owner) has filed a Form 3 on TITAN PHARMACEUTICALS INC |
| 06/09/2022 |
SC 13D/A
| Lazar David E. reports a 4.9% stake in Oxbridge Re Holdings Limited |
|
|